Nortran Pharmaceuticals Inc. and Hoechst Marion Roussel announce collaborativeagreement

Vancouver, Canada -- Nortran Pharmaceuticals Inc., the Canadian drug discovery company, and Hoechst Marion Roussel ("Hoechst"), the global pharmaceutical subsidiary of Hoechst AG, today announced the signing of a collaborative agreement in the area of cardiac arrhythmias. This collaboration will capitalize on the complementary expertise of the two companies in this area.

Under the terms of the agreement Nortran and Hoechst Marion Roussel will test investigational antiarrhythmic compounds developed by both companies. The companies will evaluate the pharmacological profiles of their compounds through the use of both companies' proprietary electrophysiological models and other preclinical tests.

"We are delighted to be working with a company of Hoechst Marion Roussel's calibre who have demonstrated their leadership in the field of cardiovascular therapeutics," commented Bob Rieder, President and Chief Executive Officer of Nortran. "We are confident that this agreement will give fresh impetus to the field of antiarrhythmic drugs and create new opportunities that will benefit both the pharmaceutical industry and ultimately patients with the condition."

Nortran recently presented findings of its preclinical research on atrial fibrillation at the European Congress of Pharmacology in Budapest. "The drugs we have developed exhibit unique pharmacological properties which may lead to a new class of antiarrhythmic drug, " said Greg Beatch, Vice President Research, Nortran. "The heart rate dependent activity of our molecules is the basis for safe, effective antiarrhythmic drugs. We are very excited about the potential for our new class of antiarrhythmics. Our collaboration with Hoechst Marion Roussel can only expedite our research program."

Hoechst Marion Roussel, a world leader in pharmaceutical-based health care, is dedicated to extending human life and enhancing its quality through the discovery, development, manufacture and sale of pharmaceutical produ

Contact: Asa Zanatta
Contemporary Communications

Page: 1 2

Related medicine news :

1. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
2. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
3. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
4. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
5. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
6. Pharmaceuticals and personal care products
7. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis
8. Beyond Pharmaceuticals: Business And Academic Leaders Forecast The Future Of "Combinatorial Chemistry"
9. ONYX Pharmaceuticals Reports Phase II Clinical Trial Results At ASCO Meeting
10. The Gerontological Society of America announces Hartford Fellowship recipients
11. TB Alliance announces new drug discovery program with GlaxoSmithKline

Post Your Comments:

(Date:10/16/2018)... ... October 16, 2018 , ... With a petition (case CJ-2018-04177) filed ... McLain PLLC joins a series of lawsuits filed in states around the country against ... Massage Envy locations by Massage Envy’s massage therapists. , This lawsuit alleges that ...
(Date:10/16/2018)... ... October 16, 2018 , ... ... its mission to provide simple, easy-to-use software for biopharma companies. By pairing the ... quickly answer those crucial resourcing questions without spending millions of dollars implementing a ...
(Date:10/16/2018)... Va. (PRWEB) , ... October 16, 2018 , ... ... Oct. 23-25, 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual ... last year’s Inspections Summit that it sometimes feels difficult to keep up. The ...
(Date:10/16/2018)... Maine (PRWEB) , ... October 15, 2018 , ... ... Fluids product line, VALIDATE® Body Fluids, Order Number 205bf, for easier linearity and ... assist in the documentation of linearity, calibration verification and verification of the reportable ...
(Date:10/16/2018)... ... October 16, 2018 , ... AutismOne, ... host the proceedings of the 4th Annual International HPV Vaccine Education Symposium. , ... Wednesday, May 22, 2019, through Friday, May 24, 2019, with a keynote address ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... Association Gloves & Supplies, ... alliance with The Dentists Supply Company (TDSC). TDSC operates an online ... catalog of dental supplies through tdsc.com. This strategic alliance enhances the value proposition ...
(Date:10/16/2018)... , ... October 16, 2018 , ... Cameras and monitoring ... of the home where safety plays a key role in a family’s health and ... of “Today’s Homeowner” TV hosted a “Safe At Home” satellite media event today. ...
(Date:10/16/2018)... ... October 16, 2018 , ... The iaedp™ Foundation, ... group of healthcare treatment providers who treat the full spectrum of eating disorder ... live, two-day, 12-hour track at Symposium 2019. The courses are regularly offered ...
Breaking Medicine Technology:
Cached News: